Public COA audit
Triple Agonist
Audited September 5, 2026
Document structure and test panels align with what we expect from authentic lab reports.
- Legitimacy
- 95
- Confidence
- 92%
- Panels
- 5/7
- Purity (printed)
- 99.44%
Scored high because document structure and panels look consistent with authentic lab output and broad panel coverage (5/7).
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- CR-3XAG-30-2606-1
- Identity method
- HPLC-RTM (retention time match)
- Sample date
- 2026-06-04
- Issue date
- 2026-06-09
Original certificate
Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
Confirmed
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.44%
Heavy metals
Tested · passed
Lead, arsenic, cadmium, mercury, or similar limits.
All Not Detected (As, Cd, Cr, Hg, Pb)
Microbial
Not on this certificate file
Bioburden / microbial limits testing.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
NMT 0.05 EU/mL
Sterility
Tested · passed
Sterility testing where applicable.
No Growth
Residual solvent / water
Not on this certificate file
Residual solvents or water content limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing on this file
Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
99.44% purity by HPLC with conformity testing across 3 samples (mean 99.37%, std dev 0.0834%). Includes representative chromatogram and detailed methodology.
Identity confirmed
Triple Agonist confirmed by HPLC retention time match with reference standard.
Batch information complete
Lot CR-3XAG-30-2606-1, COA-2026-YPQE_D, Accession ACC-2026-3975. Net peptide content 31.82 mg (labeled 30mg).
Dates consistent
Received 2026-06-04, analyzed 2026-06-09, issued 2026-06-09. All dates are consistent and within normal processing timeframes.
Lab credentials present
ILS Laboratories, San Diego CA. ISO/IEC 17025 accredited. Signed by Dr. Greg Kalyuzhny, Lab Director. Verification URL and access code provided.
Comprehensive testing panel
Full QC panel includes purity/identity (HPLC), heavy metals (ICP-MS), endotoxin (USP <85>), sterility (PCR), and fentanyl screen. Microbial and residual solvent panels not included but not uncommon for research peptides.
Professional presentation
Well-formatted 2-page COA with clear tables, chromatogram, QR code verification, detailed methodology notes, and proper accreditation statements.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.